A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration
Clinical trial NCT05456828 · COMPLETED
Trial details
- NCT number
- NCT05456828
- Sponsor
- Visara, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-10
- Primary completion
- 2025-11-03
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.